The first comprehensive and multi-institutional study identified a significant association between the TP53 rare rs78378222C allele and risk of prostate cancer, glioma and colorectal adenoma in Caucasian populations but not with risk of colorectal cancer, breast cancer and melanoma in the same study populations 6. The gene discussed is TP53; the disease is glioma.